Nevertheless, patients expressing p53 showed poorer PFS among those diagnosed with locoregionally lymph node metastasis (N+) before treatment (p=0.032) (Figure 4C). The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.